science · resolves 2026-11-07
Will the new cancer therapy receive FDA approval by 2026-11-07?
Why
The historical base‑rate for a new cancer therapy to obtain FDA approval within a few weeks of its final trial read‑out is roughly 20 % (most submissions take months to a year). None of the listed sources mention an FDA decision on the therapy, and the only recent FDA‑related article (source 4) concerns a generic hormone‑patch, not the new cancer treatment. Therefore the therapy would still need to complete the FDA review and receive a positive decision before 7 Nov 2026.
Based on 14 dated sources · first forecast 2026-10-25 · 1 update · locked in and fingerprinted before the answer is known.
Related forecasts
- Will the AP municipal poll final list be announced by the SEC before 2026-10-25? 17%
- Will Rahul Gandhi appear before the special MP/MLA court in Uttar Pradesh on 2026-10-26? 81%
- Will the Fed’s October 2026 policy statement cite AI‑driven inflation as a primary concern? 11%
- Will Brazil's presidential runoff on 2026-10-27 be won by Lula? 45%
- Will Pakistan’s victory over England in Lahore be confirmed as a 2‑0 series win by 2026-10-27? 44%
- Will the Andhra Pradesh State Election Commission announce the final list of candidates for the MPTC and ZPTC polls by 2026-10-27? 81%
AI-generated forecast for information only: not betting, financial, legal or investment advice. No money is involved. How accurate is Kāla?